Grand Cayman, Caribbean

Whatsapp +33758673528    e-mail: head_office@nbscience.com

Stem Cell Therapy Clinic is located on Seven Mile Beach in Grand Cayman, a small island paradise in the Caribbean. The Cayman Islands is an English-speaking British Overseas Territory and hosts over 2 million tourists a year. There are many direct flights to Grand Cayman from major cities in the U.S. and Europe.

About Stem Cells laboratory

Scalable Manufacturing
under strict environmental and laboratory controls in accordance with cGMP.

cGMP compliant and CLIA certified, with a QMS that is globally recognized as ISO 9001:2015 and ISO 13485:2016 certified. Operated a highly regulated, FDA-compliant commercial biologics manufacturing facility for several years and is cGMP compliant, ISO9001 Certified, ISO13485 Certified, CLIA Certified and FDA registered. All clinical manufacturing occurs in a certified sterile clean room with extensive and advanced testing to assure the absence of contamination.

Innovative biotechnology company focused on developing Wharton’s jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders.

About Cayman islands

The Cayman Islands are an overseas territory of the United Kingdom in the Caribbean Sea, comprising the islands of Grand Cayman, Little Cayman, and Cayman Brac, situated about 450 miles (724 km) southwest of  Miami, FL, United States. The islands are the outcroppings of a submarine mountain range that extends northeastward from Belize to Cuba. The capital is George Town, on Grand Cayman and the main airport is named Owen Roberts International (GCM).

The Cayman Islands are a safe and popular medical tourism / vacation destination. The high level of safety is one of the reasons why so many families visit Grand Cayman every year. Over 2-million tourists visit the Cayman Islands every year, and virtually no one has any issues.

A Visa is not required for US, Canadian and European visitors, however you will require a passport to enter the country.

Is your facility licensed?

It is fully licensed healthcare facility that has been authorized to operate by the government of the Cayman Islands. As a British Overseas Territory, healthcare regulations are extremely strict, on par with the US, UK, and EU. Additionally, our entire medical staff is fully registered and licensed, and our stem cell protocols are IRB reviewed and approved by a board in the United States.

IRB-approved protocol consists of a two-day period that involves the intravenous (IV) transplant of 300 million culturally expanded human umbilical cord tissue-derived adult mesenchymal stem cells (MSCs). 

1) The treatment protocol involves the systemic administration of a culturally expanded mesenchymal stem cell product – which is not authorized in the United States.   The dosage is standardized to 300 million mesenchymal stem cells per patient split into 6 separate vials of 50 million cells to ensure smooth administration and prevent any cell clumping.

2) The facility is required to submit efficacy data every year to its IRB to continue enrolling patients. The clinic is directly regulated by the Cayman Islands Government, which has strict criteria that must be followed to conduct patient-funded clinical trials.

3) Rather than making direct claims to be able to treat specific conditions – rather the team utilizes information on the website as statistical tools using data collected from third-party peer-reviewed studies.

4) Protocols are highly regulated and patient safety is of utmost importance. The mesenchymal stem cells are ethically sourced from AATB certified, US-donated, full-term human umbilical cords and processed in our award-winning partner medical laboratory located in the USA, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified. 

The cells are tested to ISCT standards for viability to ensure they meet minimum QA requirements multiple times before treatment. To ensure cell safety, we conduct advanced therapy testing for sterility, endotoxins, mycoplasma, HIV-1/HIV-2, Hepatitis B, Hepatitis C, and Syphilis on the cells post expansion as well as the donated umbilical cords.

Confirmation of identity (URMC Flow Cytometry) testing is also conducted to ensure post-thaw viability, and MSC phenotype expression (CD73+, CD90+, CD105, etc.). This ensures a standardized cell product which helps the medical team provide further insight into treatment efficacy

5) Is transparent with any inquiries concerning treatment protocols, efficacy data, and cell products, the facility and staff never aim to mislead anyone or make false claims on the website that cannot be backed up with real data.

6) Treatment protocol is designed in such a way as to ensure patient safety – this would not be possible if there were not hundreds of peer-reviewed studies that came before ours that showcased the safety of mesenchymal stem cells derived from umbilical cord tissue when used in a clinical setting.

NOTE: This post is intended to provide general information about regenerative medicine, and related areas. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Whatsapp +33758673528    e-mail: head_office@nbscience.com

Seven Mile Beach Grand Cayman (2022) – All You Need To Know

Recommended hotel:

The Ritz-Carlton *****, Grand Cayman

PO Box 32348 KY1-1209, Seven Mile Beach
Grand Cayman, KY1-1209 Cayman Islands

Articles about stem cell therapy :

(please contact Editor to get original articles)

ALS
ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles

ALS
Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy

ALS
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

ALS
NurOwn, phase 2, randomized, clinical trial in patients with ALS

ALS
Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS) – In Vitro Evidence from Primary Motor Neuron Cultures, NSC-34 Cells, Astrocytes and Microglia

ALS
Phase I Trial of Repeated Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis

ALS
Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?

ALS
Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside

Alzheimer’s
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview

Alzheimer’s
Stem cell therapy for Alzheimer’s disease

Alzheimer’s
Alzheimer’s Disease and Stem Cell Therapy

Alzheimer’s
Immunomodulatory role of mesenchymal stem cells in Alzheimer’s disease

Alzheimer’s
Stem cell therapies for Alzheimer’s disease is it time?

Alzheimer’s
Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks

Alzheimer’s
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease

Alzheimer’s
Stem Cell Treatment for Alzheimer’s Disease

Alzheimer’s
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Asthma
Small extracellular vesicles derived from human MSCs prevent allergic airway inflammation via immunomodulation on pulmonary macrophages

Asthma
Mesenchymal Stem Cells Recruit CCR2+ Monocytes to Suppress Allergic Airway Inflammation

Autoimmune
Immunoregulation by Mesenchymal Stem Cells: Biological Aspects and Clinical Applications

Autoimmune
Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study

Autoimmune
Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases

COPD
Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis

COPD
Human umbilical cord mesenchymal stem cell-derived extracellular vesicles ameliorate airway inflammation in a rat model of chronic obstructive pulmonary disease (COPD)

COPD
Mesenchymal stromal cell therapy in COPD: from bench to bedside

COPD
Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell

COPD
Stem cell therapy in chronic obstructive pulmonary disease. How far is it to the clinic?

COPD
Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases

COPD
Mesenchymal Stem Cell Administration in Patients with Chronic Obstructive Pulmonary Disease: State of the Science

COPD
Can Youthful Mesenchymal Stem Cells from Wharton’s Jelly Bring a Breath of Fresh Air for COPD?

COPD
Mesenchymal stem cells and immunomodulation: current status and future prospects

COPD
Stem cell therapies for chronic obstructive pulmonary disease: current status of pre-clinical studies and clinical trials

COPD
Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study

COVID-19
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

COVID-19
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?

COVID-19
Taming of Covid-19: potential and emerging application of mesenchymal stem cells

COVID-19
Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome

COVID-19
Taming of Covid-19: potential and emerging application of mesenchymal stem cells

COVID-19
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients

COVID-19
Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials

COVID-19
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment

Chronic Inflammation
Immune modulation by mesenchymal stem cells

Chronic Inflammation
Shattering barriers toward clinically meaningful MSC therapies

Crohn’s Disease
Mesenchymal Stem Cells for Perianal Crohn’s Disease

Crohn’s Disease
Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn’s Disease: A Randomized Controlled Clinical Trial

Crohn’s Disease
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Crohn’s Disease
Mesenchymal stromal cells: clinical challenges and therapeutic opportunities

Crohn’s Disease
Efficacy of stem cells therapy for Crohn’s fistula: a meta-analysis and systematic review

Crohn’s Disease
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact

Crohn’s Disease
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial

Diabetes
Current Status of Stem Cell Treatment for Type I Diabetes Mellitus

Diabetes
Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America

Diabetes
Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

Diabetes
Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes

Diabetes
Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders

Diabetes
Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data

Diabetes
Therapeutic Potential of Mesenchymal Stem Cells for Diabetes

Diabetes
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells

Diabetes
Immunomodulation by Mesenchymal Stem Cells

Diabetes
Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges

Diabetes
Regenerative and Transplantation Medicine: Cellular Therapy Using Adipose Tissue-Derived Mesenchymal Stromal Cells for Type 1 Diabetes Mellitus

Diabetes
Identifying the Therapeutic Significance of Mesenchymal Stem Cells

Diabetes
Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes

Fibromyalgia
Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives

Heart Failure
Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue

Heart Failure
Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity

Heart Failure
Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue

Heart Failure
Mesenchymal Stem Cells in Cardiology

Heart Failure
Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8)

Immunomodulation
Mesenchymal stem cells and immunomodulation: current status and future prospects

Immunomodulation
Human mesenchymal stem cells modulate allogeneic immune cell responses

Kidney Disease
Stem cell-based treatment of kidney diseases

Kidney Disease
Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance

Kidney Disease
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients

Kidney Disease
Stem cells: a potential treatment option for kidney diseases

Kidney Disease
Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease

Kidney Disease
Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases

Kidney Disease
Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models

Kidney Disease
Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells

Kidney Disease
The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model

Liver Disease
Stem Cell-Based Therapies for Liver Diseases: An Overview and Update

Liver Disease
Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases

Liver Disease
Progress in mesenchymal stem cell–based therapy for acute liver failure

Liver Disease
Stem cell transplantation for treating liver diseases: progress and remaining challenges

Liver Disease
Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies

Liver Disease
Systematic review: the effects of autologous stem cell therapy for patients with liver disease

Liver Disease
Mesenchymal stem cells-based therapy in liver diseases

Lupus
Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience

Lupus
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

Lupus
Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus

Lupus
Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients

Lupus
Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience

Lupus
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study

Lupus
Human umbilical cord mesenchymal stem cells derived extracellular vesicles regulate acquired immune response of lupus mouse in vitro

Lyme Disease
Transplantation of Human Embryonic Stem Cells in Patients with Multiple Sclerosis and Lyme Disease

Lyme Disease
Single-photon emission tomography imaging in patients with Lyme disease treated with human embryonic stem cells

Mesenchymal Stem Cells
Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy

Mesenchymal Stem Cells
Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases

Mesenchymal Stem Cells
Mesenchymal stromal cells: sensors and switchers of inflammation

Mesenchymal Stem Cells
Extracellular vesicles derived from Wharton’s Jelly mesenchymal stem cells inhibit the tumor environment via the miR-125b/HIF1α signaling pathway

Multiple Sclerosis
The potential use of mesenchymal stem cells for the treatment of multiple sclerosis

Multiple Sclerosis
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Multiple Sclerosis
The Potential of Human Umbilical Cord-Derived Mesenchymal Stem Cells as a Novel Cellular Therapy for Multiple Sclerosis

Multiple Sclerosis
Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies

Multiple Sclerosis
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis

Multiple Sclerosis
Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis

Multiple Sclerosis
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Multiple Sclerosis
Safety and efficacy of stem cell therapy for treatment of neural damage in patients with multiple sclerosis

Multiple Sclerosis
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study

Multiple Sclerosis
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Parkinson
Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells

Parkinson’s
Pluripotent Stem Cell-based therapy for Parkinson’s disease: current status and future prospects

Parkinson’s
Mesenchymal stem cell therapy in Parkinson’s disease animal models

Parkinson’s
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration

Parkinson’s
Cell replacement therapy for Parkinson’s disease: how close are we to the clinic?

Parkinson’s
Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson’s Disease

Parkinson’s
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Parkinson’s Disease
Stem Cell-Based Therapies for Parkinson Disease

Parkinson’s Disease
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Parkinson’s Disease
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Parkinson’s Disease
Stem Cell-Based Therapies for Parkinson Disease

Parkinson’s Disease
Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine

Parkinson’s Disease
Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson’s Disease

Primary Biliary Cirrhosis
Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis

Rheumatoid Arthritis
Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy

Rheumatoid Arthritis
Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications

Rheumatoid Arthritis
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study

Rheumatoid Arthritis
Recent Developments in Clinical Applications of Mesenchymal Stem Cells in the Treatment of Rheumatoid Arthritis and Osteoarthritis

Rheumatoid Arthritis
Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?

Rheumatoid Arthritis
Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis

Spinal Cord Injury
Treatment of spinal cord injury with mesenchymal stem cells

Stroke
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke

Stroke
Stem Cell Transplantation Therapy for Multifaceted Therapeutic Benefits after Stroke

Stroke
Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles

Stroke
Stem Cell Therapy for Abrogating Stroke-Induced Neuroinflammation and Relevant Secondary Cell Death Mechanisms

Stroke
Autologous Mesenchymal Stem Cells in Chronic Stroke

Stroke
A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke

Stroke
Efficacy of stem cell-based therapies for stroke

Stroke
Recent Advances in Cell-Based Therapies for Ischemic Stroke

Traumatic Brain Injury
The neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury

Traumatic Brain Injury
Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury

Traumatic Brain Injury
Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury

Traumatic Brain Injury
Cell-Based therapy for traumatic brain injury

Traumatic Brain Injury
Genetically Modified Mesenchymal Stem Cells: The Next Generation of Stem Cell-Based Therapy for TBI

Traumatic Brain Injury
Mesenchymal Stem Cells of Dental Origin-Their Potential for Anti-inflammatory and Regenerative Actions in Brain and Gut Damage

Categories: Stem Cells therapy

NBScience

contract research organization

stem cell therapy